Could light therapy ease nerve pain from childhood cancer treatment?
NCT ID NCT07019259
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a six-week at-home light therapy program is practical and helpful for childhood cancer survivors who have nerve pain or numbness from chemotherapy. Twenty survivors aged 5 and older will use a light therapy device on their symptoms for 15 minutes, three days a week. Researchers will measure how well participants stick with the program and whether symptoms improve.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Anodyne Therapy System (light therapy device)
- What this could lead to
- If successful, this could offer a simple, at-home way to reduce nerve pain and numbness in childhood cancer survivors.
- What could go wrong
- This is a small, early feasibility study with only 20 participants, so results may not apply widely. Light therapy may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yale New Haven Health Park Avenue Medical Center
RECRUITINGTrumbull, Connecticut, 06611, United States
-
Yale New Haven Health Smilow York Street Hospital
RECRUITINGNew Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can a new drug shield nerves from Chemotherapy's side effects?
- Smartwatch could spot nerve damage before it starts
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?